![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Leo Pharma A/s Ballerup Dk, based in Denmark, is a pharmaceutical company.
One of their significant offerings is Sodium fusidate, Process II, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2021-042 - Rev 00
This Chemical Type CEP, issued on June 04, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 848 associated with this CEP further emphasizes